Innovex insider funds sell 4.95M shares at $28.71
Innovex International, Inc. (INVX) had multiple affiliated investment funds report trades in its common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Innovex International, Inc. (INVX) had multiple affiliated investment funds report trades in its common stock. On 2026-08-10, funds associated with Amberjack Capital and Intervale Capital reported an aggregate net sale of 4,954,467 shares of common stock at $28.71 per share in an underwritten secondary offering to Barclays Capital Inc. One fund, Intervale Capital Fund III, L.P., is reported as acquiring 45,533 shares at the same price. These positions are held indirectly through various limited partnerships and general partners, which exercise voting and dispositive power over the shares. Following the transactions, Amberjack Capital Fund II, L.P. held 13,164,573 shares and Innovex Co-Invest Fund II, L.P. held 3,073,822 shares indirectly.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 5,000,000 shares
Net Sell
6 txns
Insider
INNOVEX CO-INVEST FUND, L.P., Innovex Co-Invest Fund GP, L.P., Interval Capital Associates II, LLC, Intervale Capital Associates III, LLC, Intervale Capital Fund II, L.P., Intervale Capital Fund II-A, L.P., Intervale Capital Fund III, L.P., Intervale Capital GP II, L.P., Intervale Capital GP III, L.P.
Role
Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner
Sold
5,000,000 shs ($143.55M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F7, F8, F9, F10 | 3,706,801 | $28.71 | $106.42M |
| Sale | Common Stock F2, F7, F8, F9, F10 | 865,508 | $28.71 | $24.85M |
| Sale | Common Stock F3, F7, F8, F9, F10 | 205,126 | $28.71 | $5.89M |
| Sale | Common Stock F4, F7, F8, F9, F10 | 176,944 | $28.71 | $5.08M |
| Sale | Common Stock F5, F7, F8, F9, F10 | 88 | $28.71 | $3K |
| Sale | Common Stock F6, F7, F8, F9, F10 | 45,533 | $28.71 | $1.31M |
Holdings After Transaction:
Common Stock — 13,164,573 shares (Indirect, By Amberjack Capital Fund II, L.P.);
Common Stock — 3,073,822 shares (Indirect, By Innovex Co-Invest Fund II, L.P.);
Common Stock — 728,498 shares (Indirect, By Innovex Co-Invest Fund, L.P.);
Common Stock — 628,411 shares (Indirect, By Intervale Capital Fund II, L.P.);
Common Stock — 311 shares (Indirect, By Intervale Capital Fund II-A, L.P.);
Common Stock — 161,707 shares (Indirect, By Intervale Capital Fund III, L.P.)
Footnotes (10)
- F1. Consists of shares of common stock, par value $0.01 per share, of the Issuer held directly by Amberjack Capital Fund II, L.P. ("Common Stock") that were sold in an underwritten secondary offering (the "Offering") at a price to Barclays Capital Inc. (the "Underwriter") of $28.71 per share.
- F2. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund II, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
- F3. Consists of shares of Common Stock held directly by Innovex Co-Invest Fund, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
- F4. Consists of shares of Common Stock held directly by Intervale Capital Fund II, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share
- F5. Consists of shares of Common Stock held directly by Intervale Capital Fund II-A, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
- F6. Consists of shares of Common Stock held directly by Intervale Capital Fund III, L.P. that were sold in the Offering at a price to the Underwriter of $28.71 per share.
- F7. The general partner of (i) Amberjack Capital Fund II, L.P. is Amberjack Capital GP II, L.P., and the general partner of such general partner is Amberjack Capital Associates II, LLC, (ii) Innovex Co-Invest Fund II, L.P. is Innovex Co-Invest Fund II GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iii) Innovex Co-Invest Fund, L.P. is Innovex Co-Invest Fund GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iv) Intervale Capital Fund II, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, (v) Intervale Capital Fund II-A, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, and (vi) Intervale Capital Fund III, L.P. is Intervale Capital GP III, L.P., and the general partner of such general partner is Intervale Capital Associates III, LLC.
- F8. (Continued from footnote 7) Funds affiliated with Amberjack Capital Partners, L.P. ("Amberjack Capital Partners") are referred to as the "Amberjack Funds".
- F9. By virtue of their relationships, the foregoing general partners control all voting and dispositive power over the reported shares held by such Amberjack Fund and therefore may be deemed to be the beneficial owner of such shares. The sole member of Amberjack Capital Associates II, LLC, Innovex Co-Invest Associates, LLC, Intervale Capital Associates II, LLC and Intervale Capital Associates III, LLC is Amberjack Capital Partners, and the general partner of Amberjack Capital Partners is Amberjack Management, LLC ("Amberjack Management"). By virtue of their relationships, Amberjack Capital Partners and Amberjack Management control all voting and dispositive power over the reported shares held by all the Amberjack Funds and therefore may be deemed to be the beneficial owner of such shares. Jason Turowsky is managing partner of Amberjack Management.
- F10. (Continued from footnote 9) Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests in the securities.
Key Figures
Net shares sold: 4,954,467 shares
Offering price: $28.71 per share
Amberjack Capital Fund II post-transaction holding: 13,164,573 shares
+3 more
6 metrics
Net shares sold
4,954,467 shares
Aggregate net sell shares reported across all transactions on 2026-08-10
Offering price
$28.71 per share
Price to Barclays Capital Inc. in the underwritten secondary offering
Amberjack Capital Fund II post-transaction holding
13,164,573 shares
Common stock held indirectly following its reported sale on 2026-08-10
Innovex Co-Invest Fund II post-transaction holding
3,073,822 shares
Common stock held indirectly following its reported sale on 2026-08-10
Innovex Co-Invest Fund, L.P. shares sold
205,126 shares
Sale at $28.71 per share in the underwritten secondary offering
Intervale Capital Fund III, L.P. acquired shares
45,533 shares
Reported as acquired at $28.71 per share on 2026-08-10
Key Terms
underwritten secondary offering, beneficial owner, voting and dispositive power
3 terms
underwritten secondary offering financial
"shares of common stock ... were sold in an underwritten secondary offering"
An underwritten secondary offering is when existing shareholders sell a block of already-issued shares and an investment bank agrees to buy and resell them to the public, guaranteeing the sale will go through. Think of it as a store owner pre-selling a large shipment to a wholesaler who then sells it to customers; for investors, it can increase the number of shares available, affect short-term price pressure, and signal that insiders are taking profits or diversifying holdings.
beneficial owner financial
"therefore may be deemed to be the beneficial owner of such shares"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
voting and dispositive power financial
"control all voting and dispositive power over the reported shares"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions were reported for INVX on 2026-08-10?
On 2026-08-10, affiliated funds of Amberjack and Intervale reported net sales of 4,954,467 Innovex (INVX) shares at $28.71 per share in an underwritten secondary offering, alongside one reported acquisition of 45,533 shares.
Were any INVX insider holdings reported after these transactions?
Yes. After the trades, Amberjack Capital Fund II, L.P. held 13,164,573 shares of Innovex (INVX), while Innovex Co-Invest Fund II, L.P. held 3,073,822 shares, both as indirect holdings through their partnership structures.
Was the INVX Form 4 filed under a Rule 10b5-1 trading plan?
The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed (box unchecked). The footnotes describe the transactions as part of an underwritten secondary offering, not as trades pursuant to a pre-arranged 10b5-1 plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
